In vitro effects of Saiboku-to on cytokine production from peripheral blood mononuclear cells of bronchial asthma patients

Citation
Y. Tohda et al., In vitro effects of Saiboku-to on cytokine production from peripheral blood mononuclear cells of bronchial asthma patients, CLIN DRUG I, 17(6), 1999, pp. 461-466
Citations number
25
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
CLINICAL DRUG INVESTIGATION
ISSN journal
11732563 → ACNP
Volume
17
Issue
6
Year of publication
1999
Pages
461 - 466
Database
ISI
SICI code
1173-2563(199906)17:6<461:IVEOSO>2.0.ZU;2-2
Abstract
Objective: This study aimed to evaluate the efficacy of Saiboku-to, a Japan ese traditional herbal medicine (Kampo), on the production of interleukin-3 (IL-3), interleukin-4 (IL-4), interleukin-5 (IL-5), interferon-gamma (IFN- gamma) and interleukin-2 (IL-2) by peripheral blood mononuclear cells in br onchial asthma patients following antigenic stimulus by the house dust mite . Design: Twelve bronchial asthma patients with IgE RAST (radio-allergosorben t test) scores to mites of 3 and over were enrolled in the study. Separated mononuclear cells from the patients' blood were suspended in a 24-hole pla te with 10% fetal calf serum (FCS) and RPMI-1640 medium. Mite antigen was a dded to the above cell-suspension (final concentration 10 mg/ml) and cultur ed for 72 hours at 37 degrees C in 5% CO2. Saiboku-to (TJ-96, Tsumura & Co. ) was added to the above sample system at the same time as mite antigen and cultured for 72 hours under the same conditions. After 72 hours of incubat ion, the amount of various cytokines (IL-2, IL-3, IL-4, IL-5, INF-gamma) wa s measured using enzyme-linked immunoabsorbent assay kits. Results: Saiboku-to 500 mg/L significantly inhibited the production of IL-3 and IL-4 from peripheral blood mononuclear cells. Moreover, it significant ly increased the production of INF-gamma from peripheral blood mononuclear cells. Conclusion: These preliminary findings suggest that Saiboku-to could be con sidered as one of a new class of anti-asthmatic drugs because of its influe nce on cytokine production.